Navigation Links
American Oriental Bioengineering to Participate in the 2009 UBS Greater China Conference
Date:1/12/2009

NEW YORK, Jan. 12 /PRNewswire-Asia-FirstCall/ -- American Oriental Bioengineering, Inc. (NYSE: AOB) ("AOBO" or "the Company"), a leading marketer, distributor and manufacturer of pharmaceutical and healthcare products in China, today announced that the Company will attend and undertake one-on-one meetings at the 2009 UBS Greater China Conference, held at the Pudong Shangri-La hotel in Shanghai. Management is currently scheduled to meet with institutional investors on January 12 and 13, 2009.

For more details on the conference, please contact your UBS institutional sales representative.

About American Oriental Bioengineering Inc.

American Oriental Bioengineering, Inc., is a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter products in China.


'/>"/>
SOURCE American Oriental Bioengineering Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. American Oriental Bioengineering Comments on Recent Property Purchase
2. Tips from the journals of the American Society for Microbiology
3. Elsevier Introduces The American Journal of Medicine Blog
4. The American Ceramic Society releases new ACerS-NIST phase equilibria diagrams CD-ROM database
5. Transgenomic Receives Accreditation From College of American Pathologists
6. Proteolix Announces Positive Data From Two Ongoing Phase 2 Clinical Trials of Carfilzomib in Multiple Myeloma at the 50th Annual Meeting of the American Society of Hematology
7. Multiple Vimpat(R) (lacosamide) Studies Presented at American Epilepsy Society Annual Meeting
8. Proteolix Presents Preclinical Data for Oral Proteasome Inhibitor PR-047 at the 50th Annual Meeting of the American Society of Hematology
9. 100% Non-Incision Cosmetic Surgery, The 'Frame Thread Lift,' Debuts December 14, 2008 At American Academy Of Anti-Aging Medicine In Las Vegas
10. BioCryst to Present Three Posters During the 50th American Society of Hematology Annual Meeting and Exposition
11. Portola Data on Its Novel Syk Inhibitors and Novel Universal Factor Xa Inhibitor Antidote to be Presented at 2008 American Society of Hematology (ASH) Meeting

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)..., MOUNTAIN VIEW, Calif. Nov. 5, 2009 Complet...cing company, today announced publication of a rep...etary DNA sequencing platform, including analysis .... The consumables cost for these three genomes seq...rrays ranged from $8,005 for 87x coverage to $1,72...
(Date:11/6/2009)..., AURORA, Ontario, Nov. 6 /PRNewswire-FirstCall/ ...heets: HXBPF) today announced that John Docherty, ...t at Merriman Curhan Ford,s 6th annual Investor Su...l Hotel in New York City. Mr. Docherty will provi...velopment programs L-DOS47 and Topical Interferon ...
(Date:11/6/2009)..., SPRING VALLEY, Calif., Nov. 6 C...warded a Small Business Innovative Research (SBIR)...h and Material command. Under terms of the agreeme...nts (ASRs) for the diagnosis of Dengue virus. ,...at represents a major threat to military forces de...
(Date:11/5/2009)... TRANSPORTATION -- Gone hybrid . . . , Fuel e...iles are now posted at the www.fueleconomy.gov w...oped and maintains for the U.S. Department of Ener...ine of the top 10 vehicles on the best fuel econom...us (51 MPG city; 48 highway). "This list proves th...
Breaking Biology Technology:Complete Genomics publishes in Science on low-cost sequencing of 3 human genomes 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 3Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3
...November 6 deCODE genetics,(Nasdaq: DCGN ) today...the,quarter ended September 30, 2008. A conference...rating highlights and a strategic update will,be w...m EST/1pm GMT,(details below)., Operating loss fo...ed,to $22.2 million for the third quarter 2007. Op...
...t to host call and webcast today at 5:00 p.m. East...ent business highlights -, SAN DIEGO, Calif., Nov... ), a biopharmaceutical company focused on,the tre...-related,disorders, today announced unaudited fina...September 30, 2008., Three Months Ended September...
...call scheduled for November 6, 2008 at 1:30 p.m. (... at http://www.adventrx.com , SAN DIEGO, Nov. 6 ...opharmaceutical company focused on in-licensing,de...andidates primarily for,the treatment of cancer, t...h and nine-month periods ended September 30, 2008....
Other Biology Technology:deCODE genetics Announces Third Quarter 2008 Financial Results 2deCODE genetics Announces Third Quarter 2008 Financial Results 3deCODE genetics Announces Third Quarter 2008 Financial Results 4deCODE genetics Announces Third Quarter 2008 Financial Results 5deCODE genetics Announces Third Quarter 2008 Financial Results 6deCODE genetics Announces Third Quarter 2008 Financial Results 7deCODE genetics Announces Third Quarter 2008 Financial Results 8deCODE genetics Announces Third Quarter 2008 Financial Results 9deCODE genetics Announces Third Quarter 2008 Financial Results 10deCODE genetics Announces Third Quarter 2008 Financial Results 11deCODE genetics Announces Third Quarter 2008 Financial Results 12Orexigen(R) Therapeutics Announces Third Quarter 2008 Financial Results 2Orexigen(R) Therapeutics Announces Third Quarter 2008 Financial Results 3Orexigen(R) Therapeutics Announces Third Quarter 2008 Financial Results 4Orexigen(R) Therapeutics Announces Third Quarter 2008 Financial Results 5Orexigen(R) Therapeutics Announces Third Quarter 2008 Financial Results 6Orexigen(R) Therapeutics Announces Third Quarter 2008 Financial Results 7Orexigen(R) Therapeutics Announces Third Quarter 2008 Financial Results 8Orexigen(R) Therapeutics Announces Third Quarter 2008 Financial Results 9ADVENTRX Pharmaceuticals Reports Third Quarter 2008 Financial Results and Business Update 2ADVENTRX Pharmaceuticals Reports Third Quarter 2008 Financial Results and Business Update 3ADVENTRX Pharmaceuticals Reports Third Quarter 2008 Financial Results and Business Update 4ADVENTRX Pharmaceuticals Reports Third Quarter 2008 Financial Results and Business Update 5ADVENTRX Pharmaceuticals Reports Third Quarter 2008 Financial Results and Business Update 6ADVENTRX Pharmaceuticals Reports Third Quarter 2008 Financial Results and Business Update 7ADVENTRX Pharmaceuticals Reports Third Quarter 2008 Financial Results and Business Update 8
(Date:11/9/2009)...pid, mysterious death of phytoplankton in the Nort...cientists at Rutgers University and the Woods Hole...ical may hold unexpected promise in cancer researc...pid, or fatty compound, in a virus that has been a...lankton that plays a major role in the global carb...
(Date:11/8/2009)...TH INTELLECTUAL DISABILITIES: AN OPPORTUNITY FOR H...volving adults with intellectual disabilities foun...knowledge after taking a semi-weekly class for fou...ccepted term for mental retardation, have slightly...preventable chronic diseases compared to the gener...
(Date:11/6/2009)...l Center and the Chinese Academy of Sciences (CAS)... on Taste and Smell Research. Organized by Monell ... the first international meeting on taste and smel...cutive Officer, American Association for the Advan...ce magazine, will open the meeting with a plenary ...
Breaking Biology News(10 mins):Newly discovered fat molecule: An undersea killer with an upside 2Newly discovered fat molecule: An undersea killer with an upside 3Newly discovered fat molecule: An undersea killer with an upside 4Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 2Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 3Monell Center joins with CAS to host Beijing meeting on taste and smell research 2 248 million NIH grant for heart cell development and study 59898 1 248 million NIH grant for heart cell development and study 59898 2Growing cartilage from stem cells 10456 1Prolonged Use of Pacifier Linked to Speech Problems 59896 1
... prediction program by computer scientists at Wash...sts to predict the very beginnings of gene transcr...rs thereby defining the first exon of the gene. , ...WINSCAN is called N-SCAN. Michael Brent, Ph.D. pro...y in St. Louis, together with Samuel S. Gross, the...
...sults more accurate than PSA , Researchers at the...r have identified a panel of 22 biomarkers that to...ate cancer than the current prostate specific anti.... 22 issue of the New England Journal of Medicine.... 331 prostate cancer patients prior to surgery, an...
...or its therapeutic effect on burned or irritated s... as a healthful additive to your fruits and veggie...gel from the tropical plant that can be used as an...of fresh produce. The gel, which does not appear t...s a safe, natural and environmentally-friendly alt...
Other Biology News:Modification of program enables prediction of gene transcription 2Modification of program enables prediction of gene transcription 3U-M researchers identify new blood test for prostate cancer 2U-M researchers identify new blood test for prostate cancer 3Aloe vera coating may prolong freshness, safety of fruits and vegetables 2
MHC Volumes 1 & 2 from Promega
Custom Production Service from AbD Serotec
MitoScreen (JC-1) Kit from BD Biosciences Pharmingen
Single-stranded carrier DNA, 3 x 1 ml from Dualsystems Biotech AG
Biology Products: